Legault Pierre - Insider Non-Derivative Transactions at Syndax Pharmaceuticals Inc (SNDX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 7, 2024, Legault Pierre's relationship to Syndax Pharmaceuticals Inc (SNDX) is Director, and currently has 65,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SNDX insiders.
Data Source: SEC.
Legault Pierre - Insider Non-Derivative Transactions of SNDX Common Stock
Legault Pierre - Insider Non-Derivative Transactions at SNDX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 8, 2024 | Acquisition -- (Common Stock) | 17000 | 0 | 65000 |
| Feb 3, 2023 | Acquisition -- (Common Stock) | 16000 | 0 | 48000 |
| Jan 14, 2023 | Sell -- (Common Stock) | 5000 | 27 | 32000 |
| Jan 14, 2023 | Sell -- (Common Stock) | 10000 | 27 | 32000 |
| Jan 14, 2023 | M -- (Common Stock) | 5000 | 13.58 | 37000 |
| Jan 14, 2023 | M -- (Common Stock) | 10000 | 13.58 | 42000 |
| Jan 13, 2023 | Sell -- (Common Stock) | 24000 | 26.74 | 32000 |
| Jan 13, 2023 | M -- (Common Stock) | 24000 | 9.47 | 56000 |